Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

GenKyoTex S.A. buy melinda

GenKyoTex S.A.
Start price
€17.98
30.01.18 / 50%
Target price
€19.00
31.07.18
Performance (%)
-6.45%
End price
€16.82
31.07.18
Summary
This prediction ended on 31.07.18 with a price of €16.82. With a performance of -6.45%, the BUY prediction by melinda finished with a loss. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
GenKyoTex S.A. - - - -
iShares Core DAX® 0.060% 1.215% 18.128% 70.406%
iShares Nasdaq 100 -3.065% -0.519% 2.080% 103.787%
iShares Nikkei 225® -2.094% -3.066% 11.655% 45.417%
iShares S&P 500 -1.657% -0.069% 1.103% 64.908%

According to melinda what are the pros and cons of GenKyoTex S.A. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread GenKyoTex S.A. diskutieren
Prediction Buy
Perf. (%) -6.45%
Target price 19.000
Change
Ends at 31.07.18

Biotechnologie und Medizintechnik SecteurRecherche Agenda 31/01 Publishing Business-Trends



Beruf
Logo Genkyotex
Nach der Übernahme von 100% GenKyoTex änderte Genticel den Namen in GenKyoTex. Die neue Gruppe ist spezialisiert auf die Entwicklung von NOX-Therapien. , Entzündungen, Brennen, Schmerzen, Krebs Progression und Neurodegeneration GenKyoTex einen therapeutischen Ansatz auf der selektiven Hemmung von NOX-Enzyme basieren annehmen, dass viele pathologische Prozesse wie Fibrose verstärken.
Am Ende 2016 hat die Gruppe einen Portfolio von 2 Produkten: GKT831 (Behandlung von primär biliäre Cholangitis) und GKT771 (Behandlung von Schmerzen und Entzündungen).

Anzahl der Angestellten: 7 Personen.



melinda 
0
Report Share
30.01.18
Prediction Buy
Perf. (%) -6.45%
Target price 19.000
Change
Ends at 31.07.18

(Laufzeit überschritten)

melinda 
0
Report Share
31.07.18

Stopped prediction by melinda for GenKyoTex S.A.

buy
GenKyoTex S.A.

Start price
Target price
Perf. (%)
€3.18
28.09.21
€3.60
-
24.10.21

Could be worthwhile Investment >10% per year
melinda 
28.09.21 50%
buy
GenKyoTex S.A.

Start price
Target price
Perf. (%)
€44.70
15.06.16
€50.00
16.12.16
-40.72%
16.12.16

Could be worthwhile Investment >10% per year
melinda 
14.08.19 50%
buy
GenKyoTex S.A.

Start price
Target price
Perf. (%)
€41.80
07.04.16
€50.00
21.04.16
26.08%
21.04.16

Could be worthwhile Investment >10% per year
melinda 
14.08.19 50%